Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shin Egawa

Showing results (11-20 of 362) with videos related to

Pageof 37
Sort By:
International Journal of Clinical Oncology|May 11, 2011
The role of lymph node dissection in the management of prostate cancerJun Miki, Shin Egawa
European Urology|September 7, 2016
Re: Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE TrialTakahiro Kimura, Shin Egawa
European Urology|April 10, 2012
What is needed for improved patient care in upper urinary tract urothelial carcinoma?Shin Egawa, Takahiro Kimura
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 28, 2016
[Laparoscopic radical prostatectomy (LRP)]Mahito Atsuta, Shin Egawa
European Urology|December 5, 2020
Re: Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with AtezolizumabWataru Fukuokaya, Shin Egawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 26, 2003
[PSA follow-up after radical prostatectomy]Shin Egawa, Shiro Baba
European Urology|January 30, 2013
Words of Wisdom: re: international variation in prostate cancer incidence and mortality ratesHidetoshi Kuruma, Shin Egawa
European Urology|March 15, 2016
Words of Wisdom. Re: Randomized Controlled Trial of Early Zoledronic Acid in Men with Castration-sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance)Takahiro Kimura, Shin Egawa
Nature Reviews. Urology|June 1, 2017
Personalized peptide vaccines and their relation to other therapies in urological cancerTakahiro Kimura, Shin Egawa, Hirotsugu Uemura
European Urology|March 26, 2019
Re: A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial BiopsyFumihiko Urabe, Takahiro Ochiya, Shin Egawa
Pageof 37

Showing results (11-20 of 362) with videos related to

Sort By:
Pageof 37
International Journal of Clinical Oncology|May 11, 2011
The role of lymph node dissection in the management of prostate cancerJun Miki, Shin Egawa
European Urology|September 7, 2016
Re: Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE TrialTakahiro Kimura, Shin Egawa
European Urology|April 10, 2012
What is needed for improved patient care in upper urinary tract urothelial carcinoma?Shin Egawa, Takahiro Kimura
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 28, 2016
[Laparoscopic radical prostatectomy (LRP)]Mahito Atsuta, Shin Egawa
European Urology|December 5, 2020
Re: Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with AtezolizumabWataru Fukuokaya, Shin Egawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 26, 2003
[PSA follow-up after radical prostatectomy]Shin Egawa, Shiro Baba
European Urology|January 30, 2013
Words of Wisdom: re: international variation in prostate cancer incidence and mortality ratesHidetoshi Kuruma, Shin Egawa
European Urology|March 15, 2016
Words of Wisdom. Re: Randomized Controlled Trial of Early Zoledronic Acid in Men with Castration-sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance)Takahiro Kimura, Shin Egawa
Nature Reviews. Urology|June 1, 2017
Personalized peptide vaccines and their relation to other therapies in urological cancerTakahiro Kimura, Shin Egawa, Hirotsugu Uemura
European Urology|March 26, 2019
Re: A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial BiopsyFumihiko Urabe, Takahiro Ochiya, Shin Egawa
Pageof 37